IFNG and rheumatoid arthritis: Anti-IFN-γ autoAbs have also been observed in autoimmune inflammatory diseases such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) [12,13], despite the unclear clinical impact.